57
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Non-culture based diagnostic tests for mycotic infections

, , , &
Pages 147-159 | Published online: 01 Apr 2010

References

  • Reiss E, Kaufman L, Kovacs J, Lindsley MD. Clinical im-munomycology In: Rose NR, ed. Manual of Clinical Immunol-ogy 6th edn. Washington DC: American Society for Microbiology, in press.
  • Rex JH, Walsh TJ, Anaissie El. Fungal infections in iatrogeni-cally compromised hosts. Adv Intern Med 1998; 43: 321–371.
  • Minamoto GY, Rosenberg AS. Fungal infections in patients with acquired immunodeficiency syndrome. Med Clin North Am 1997; 81: 381–409.
  • Andriole VT. The Garrod lecture. Current and future antifun-gal therapy: new targets for antifungal agents. J Antimicrob Chemother 1998; 44: 151–162.
  • Man KA, White TC, van Bunk JA, Bowden RA. Development of fluconazole resistance in Candida albicans causing dissemi-nated infection in a patient undergoing marrow transplantation. Clin Infect Dis 1997; 25: 908–910.
  • Walsh TJ, Chanock SJ. Diagnosis of invasive fungal infections: advances in nonculture systems. Curr Clin Top Infect Dis 1998; 18: 101–153.
  • Berenguer J, Buck M, Witebsky F, Stock F, Pizzo PA, Walsh TJ. Lysis-centrifugation blood cultures in the detection of tis-sue-proven invasive candidiasis. Disseminated versus single-or-gan infection. Diagn Microbiol Infect Dis 1993; 17: 103–109.
  • Rand KH, Houck H, Wolff M. Detection of candidemia by polymerase chain reaction. Mol Cell Probes 1994; 8: 215–221.
  • Löffler J, Hebart H, Sepe S, Schumacher U, Klingebiel T, Einsele H. Detection of PCR-amplified fungal DNA by using a PCR-ELISA system. Med Mycol 1998; 36: 275–279.
  • van Bunk JA, Myerson D, Schreckhise RW, Bowden RA. Panfungal PCR assay for detection of fungal infection in hu-man blood specimens. J Clin Microbiol 1998; 36: 1169–1175.
  • Vazquez JA. Use of polymerase chain reaction for the diagnosis of invasive Candida infection. Serodiagn Immunother Infect Dis 1994; 6: 173–178.
  • Einsele H, Hebart H, Roller G, et al. Detection and identifica-tion of fungal pathogens in blood by using molecular probes. J Clin Microbiol 1997; 35: 1353–1360.
  • Chryssanthou E, Klingspor L, Tollemar J, et al. PCR and other non-culture methods for diagnosis of invasive Candida infec-tions in allogeneic bone marrow and solid organ transplant recipients. Mycoses 1999; 42: 239–247.
  • Fujita S, Lasker BA, Lott TJ, Reiss E, Morrison CJ. Microti-tration plate enzyme immunoassay to detect PCR-amplified DNA from Candida species in blood. J Clin Microbiol 1995; 33: 962–967.
  • Shin JH, Nolte FS, Morrison CJ. Rapid identification of Can-dida species in blood cultures by a clinically useful PCR method. J Clin Microbiol 1997; 35: 1454–1459.
  • Morrison CJ. Molecular methods for the isolation, purification, and detection of Candida species DNA. Program and Abstracts of the Interscience Conference Antimicrobial Agents Chemother-apy, San Francisco, CA, September 26–29, 1999. Washington DC, American Society for Microbiology, 1999; Abstract 493.
  • Elie CM, Lott TJ, Reiss E, Morrison CJ. Rapid identification of Candida species with species-specific DNA probes. J Clin Microbiol 1998; 36: 3260–3265.
  • Choi JS, Westerman JM, Morrison CJ. Rapid differentiation of filamentous fungi using species-specific DNA probes. Program and Abstracts of the Annual Meeting of the American Society for Microbiology, Atlanta, GA, May 17–21, 1998. Washington DC: American Society for Microbiology, 1998; Abstract C–288.
  • Loeffler J. Application of PCR to detect fungi in clinical specimens. Program and Abstracts of the Interscience Conference Antimicrobial Agents Chemotherapy, San Francisco, CA, Sep-tember 26–29, 1999. Washington DC, American Society for Microbiology, 1999; Abstract 491.
  • Bretagne S, Costa JM, Bart-Delabesse E, Dheklin N, Rieux C, Cordonnier C. Comparison of serum galactomannan antigen detection and competitive polymerase chain reaction for diag-nosing invasive aspergillosis. Clin Infect Dis 1998; 26: 1407–1412.
  • Maertens J, Verhaegen J, Demuynck H, et al. Autopsy-con-trolled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive aspergillo-sis. J Clin Microbiol 1999; 37: 3223–3228.
  • Kiehn TB, Bernard EM, Gold JW, Armstrong D. Candidiasis: detection by gas-liquid chromatography of D-arabinitol, a fun-gal metabolite, in human serum. Science 1979; 206: 577–580.
  • Christensson B, Sigmundsdottir G, Larsson L. p-arabinitol - a marker for invasive candidiasis. Med Myco11999; 37: 391–396.
  • Tokunaga S, Ohkawa M, Takashima M, Seto C, Nakamura S. D-arabinitol versus mannan antigen and candidal protein anti-gen as a serum marker for Candida pyelonephritis. Eur J Clin Microbiol Infect Dis 1995; 14: 118–121.
  • Yeo SF, Zhang Y, Schafer D, Campbell S, Wong B. A rapid, automated enzymatic fluorometric assay for determination of D-arabinitol in serum. J Clin Microbiol 2000; 38: 1439–1443.
  • Walsh TJ, Merz WG, Lee JW, et al. Diagnosis and therapeutic monitoring of invasive candidiasis by rapid enzymatic detection of serum p-arabinitol. Am J Med 1995; 99: 164–172.
  • Lehtonen L, Anttila VJ, Ruutu T, et al. Diagnosis of dissemi-nated candidiasis by measurement of urine D-arabinitol/L-ara-binitol ratio. J Clin Microbiol 1996; 34: 2175–2179.
  • Christensson B, Wiebe T, Pehrson C, Larsson L. Diagnosis of invasive candidiasis in neutropenic children with cancer by determination of D-arabinitol/L-arabinitol ratios in urine. J Clin Microbiol 1997; 35: 636–640.
  • Orle K, Van Bunk J, Verweij P, Weiss J. PCR detection of Aspergillus species from bronchoalveolar lavage specimens us-ing rapid sample preparation protocol and microwell-based detection of PCR product. Program and Abstracts of the 99th General Meeting American Society for Microbiology, Chicago, IL, May 30-June 3, 1999. Washington DC: American Society for Microbiology, 1999; Abstract C–160.
  • Mulder J, McKinney N, Christopherson C, Sninsky J, Greenfield L, Kwok S. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J Clin Micro-biol 994; 32: 292–300.
  • Yoshida M. Infections in patients with hematological diseases: recent advances in serological diagnosis and empiric therapy. Int J Hematol 1997; 66: 279–289.
  • Obayashi T. Addition of perchloric acid to blood samples for colorimetric limulus test using chromogenic substrate: compari-son with conventional procedures and clinical applications. J Lab Clin Med 1984; 104: 321–330.
  • Obayashi T, Tamura H, Tanaka S, et al. A new chromogenic endotoxin-specific assay using recombined limulus coagulation enzymes and its clinical applications. Clin Chim Acta 1985; 149: 55–65.
  • Ikegami K, Ikemura K, Shimazu T, et al. Early diagnosis of invasive candidiasis and rapid evaluation of antifungal therapy by combined use of conventional chromogenic limulus test and a newly developed endotoxin specific assay. J Trauma 1988; 28: 1118–1126.
  • Yoshida M, Obayashi T, Iwama A, et al. Detection of plasma (1,3)-I3-ri-glucan in patients with Fusarium, Trichosporon, Sac-charomyces and Acremonium fungemias. J Med Vet Mycol 1997; 35: 371–374.
  • Obayashi T, Yoshida M, Tamura H, Aketagawa J, Tanaka S, Kawai T. Determination ofplasma (1,3)-I3-ri-glucan: a new di-agnostic aid to deep mycosis. J Med Vet Mycol 1992; 30: 275–280.
  • Obayashi T, Tamura H, Tanaka S, et al. Removal of limulus test-interfering factors in blood samples with perchloric acid and the improvement of the specificity of the limulus test by fractionating amebocyte lysate. In: Watson SW, Levin J, Novit-sky TJ, eds. Detection of Bacterial Endotoxins with the Limulus Amebocyte Lysate Test. New York: Alan R. Liss, 1987: 357–369.
  • Iwama A, Yoshida M, Miwa A, Obayashi T, Sakamoto S, Miura Y. Improved survival from fungemia in patients with haematological malignancies: analysis of risk factors for death and usefulness of early antifungal therapy. Eur J Haematol 1993; 51: 156–160.
  • Obayashi T, Yoshida M, Mori T, et al. Plasma (1,3)-I3-ri-glucan determination in the diagnosis of invasive deep mycosis and fungal febrile episodes. fancet 1995; 345: 17–20.
  • Hughes WT, Armstrong D, Bodey GP, et al. guidelines for the use of antimicrobial agents in neutropenic patients with unex-plained fever. Clin Infect Dis 1997; 25: 551–573.
  • Kwon-Chung KJ, Bennett JE. Histoplasmosis. In: Medical Mycology, Philadelphia: Lea & Febiger, 1992: 464–513.
  • Bradsher RW. Histoplasmosis and blastomycosis. Clin Infect Dis 1996; 22: 5102–5111.
  • Rios Fabra A, Restrepo A, Isturiz R. Fungal infection in Latin American countries. Infect Dis Clin North Am 1994; 8: 129–154.
  • Taylor ML, Granados J, Toriello C. Biological and sociocul-tural approaches of histoplasmosis in the state of Guerrero, Mexico. Mycoses 1996; 39: 375–379.
  • Suarez M, Fernandez A, Estrada A, Cisneros D. Reactividad a la histoplasmina en trabajadores de granjas avicolas en la provincia de Ciego de Avila, Cuba. Rev Inst Med Trop Siio Paulo 1992; 34: 329–333.
  • Fava SC, Fava Netto C. Epidemiologic survey of histoplasmin and paracoccidioidin sensitivity in Brasil. Rev Inst Med Trop Seto Paulo 1998; 40: 155–164.
  • Capone D, Wanke B, Monteiro PCF, Lazera MS, Andrade GN. Chronic pulmonary histoplasmosis in the state of Rio de Janeiro, Brazil. Mycopathol 1999; 145: 75–79.
  • Suzaki A, Kimura M, Kimura A, Shimada K, Meyah M, Kaufman L. An outbreak of histoplasmosis contracted by Japanese visitors to a bat-inhabited cave near Manaus, Brazil. J Med Mycol (Japan) 1995; 5: 40–43.
  • Wheat U. Histoplasmosis: experience during outbreaks in Indi-anapolis and review of the literature. Medicine 1997; 76: 339–354.
  • Tewari R., Wheat LJ, Ajello L. Agents of histoplasmosis, In: Ajello L, Hay R, eds. Topley, and Wilson's Microbiology and Microbial Infections, Medical Mycology, 9th edn. New York: Oxford University Press Inc, 1998: 373–393.
  • Heiner DC. Diagnosis of histoplasmosis using precipitin reac-tions in agar gel. Pediatrics 1958; 22: 616–629.
  • Harris JE, Deepe GS. Characterization of antigenic determi-nants in histoplasmin that stimulate Histoplasma capsulaturn-re-active T cells in vitro. Infect Immun 1988; 56: 2343–2349.
  • Zancopé-Oliveira RM, Bragg SL, Hurst SF, Peralta JM, Reiss E. Evaluation of cation exchange chromatography for the isolation of M glycoprotein from histoplasmin. J Med Vet Mycol 1993; 31: 29–41.
  • Zancopé-Oliveira RM, Bragg SL, Reiss E, Peralta JM. Im-munochemical analysis of the H and M glycoproteins from Histoplasma capsulatum, Gun Diagn Lab Immun 1994; 1: 563–568.
  • Zancopé-Oliveira RM, Bragg SL, Reiss E, Wanke B, Peralta JM. Effects of histoplasmin M antigen chemical and enzymatic deglycosylation on cross-reactivity in the enzyme-linked immu-noelectrotransfer blot method. Clin Diag Lab Immuno11994; 1: 390–393.
  • Pizzini C, Zancopé-Oliveira RM, Reiss E, Hajjeh R, Kaufman L, Peralta JM. Evaluation of a Western blot test in an outbreak of acute pulmonary histoplasmosis. Clin Diag Lab Immunol 1999; 6: 20–23.
  • Pizzini CV, Muniz MM, Peralta JM, Reiss E, Zancop6-Oliveira RM. M6todo rápido de detecção de anticorpos anti-Histo-plasma capsulatum. XX Congresso Brasileiro de Microbiologia, Salvador, Bahia, Brazil. Rio de Janeiro: Brazilian Society for Microbiology, 1999; Abstract MM064.
  • Zancopé-Oliveira RM, Reiss E, Lott TJ, Mayer LW, Deepe G. Molecular cloning, characterization and expression of the M antigen of Histoplasma capsulatum, Infect Immun 1999; 67: 1947–1953.
  • Zancopé-Oliveira RM, Pizzini CV, Muniz MM, Monteiro PCF, Peralta JM. Alternative methods to immunoidentify Histo-plasma capsulatum in culture. Program and Abstracts of the 94th General Meeting American Society of Microbiol, Las Vegas, Nevada. Washington DC: American Society for Microbiology, 1994; Abstract F–72.
  • Muniz MM. Tipagem e identificagio de cepas de Histoplasma capsulatum por métodos moleculares. MS thesis, Fundação Os-waldo Cruz, Rio de Janeiro, 1999.
  • Deepe G Jr, Durose GG. Immunobiological activity of recom-binant H antigen from Histoplasma capsulatum. Infect Immun 1995; 63: 3151–3157.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.